Einstein Experts

Professor, Medicine (Endocrinology), Einstein

Jacob A. and Jeanne E. Barkey Chair in Medicine, Einstein

Co-Director, Diabetes Research Center, Einstein

Chief, Endocrinology, Department of Medicine, Einstein and Montefiore Medical Center

Dr. Fleischer is a nationally recognized authority in diabetes treatment and research, with more than four decades of experience in the field. In the 1970s, he founded the NIH-funded Einstein’s Diabetes Research Center, which was among the first NIH-supported diabetes centers in the country. Today, it is one of only two such Centers in New York and one of only a dozen nationwide. read more...

Professor, Medicine (Endocrinology)

Director, Institute for Aging Research

Director, Nathan Shock Center of Excellence in the Basic Biology of Aging

Ingeborg and Ira Leon Rennert Chair of Aging Research

Dr. Barzilai discovered the first “longevity gene” in humans. His research established that the gene variant that leads to high HDL, or “good cholesterol,” is linked to healthy aging and extreme longevity. Dr. Barzilai has been profiled by major outlets, including The New York Times and PBS’ “NOVA scienceNow.” read more...

Professor, Obstetrics & Gynecology and Women's Health (Reproductive Endocrinology and Infertility), Einstein

Professor, Medicine (Endocrinology), Einstein

Director, Menopause Research and Treatment Center, Montefiore Medical Center

Director, Bone Density Unit, Montefiore

Dr. Freeman is a widely recognized authority on menopause, hormone replacement therapy, osteoporosis, and vitamin D deficiency. She is currently director of the Menopause Research and Treatment Center of the Bone Densitometry Unit at the Institute for Women’s Health at Montefiore Medical Center. She also serves on the editorial board of the journal Menopause. read more...

Professor, Clinical Medicine (Endocrinology), Einstein

Director, Diabetes Clinical Trials Unit, Einstein

Attending Physician, Montefiore Medical Center

An expert in diabetes prevention, Dr. Crandall is a principal investigator in the NIH-funded Diabetes Prevention Program Outcomes Study, which showed that sustaining weight loss or taking an anti-diabetic drug can stave off type 2 diabetes in people at high risk for the disease. The American Diabetes Association recently funded Dr. Crandall to study whether the wine ingredient resveratrol can prevent diabetes in patients with prediabetes. read more...

Professor, Medicine (Endocrinology)

Professor, Molecular Pharmacology

Director, Diabetes Research Center

Judy R. and Alfred A. Rosenberg Professorial Chair in Diabetes Research

Dr. Pessin directs Einstein’s Diabetes Research Center, one of only sixteen NIH-funded diabetes centers of its kind in the country. He guides the research of more than 90 scientists investigating type 1 (formerly juvenile) and type 2 (formerly adult-onset) diabetes. The center also includes training programs and community-based activities in the Bronx. Dr. Pessin’s own research focuses on insulin signaling and the mechanisms contributing to the onset of type 1 diabetes. read more...